Nuformix (LON:NFX) Trading Down 10% – What’s Next?

by · The Markets Daily

Shares of Nuformix plc (LON:NFX – Get Free Report) dropped 10% on Tuesday . The stock traded as low as GBX 0.05 ($0.00) and last traded at GBX 0.05 ($0.00). Approximately 417,744 shares traded hands during mid-day trading, a decline of 96% from the average daily volume of 10,412,084 shares. The stock had previously closed at GBX 0.05 ($0.00).

Nuformix Price Performance

The stock has a market cap of £409,655.00, a P/E ratio of -1.63 and a beta of 1.22. The business has a 50 day simple moving average of GBX 0.05 and a 200-day simple moving average of GBX 0.11. The company has a debt-to-equity ratio of 1.17, a quick ratio of 3.35 and a current ratio of 1.12.

About Nuformix

(Get Free Report)

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.

Read More